Updated: January 18, 2026
Tamoxifen Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Is Tamoxifen in shortage in 2026? Here's the latest supply update, what's causing local stock-outs, and what breast cancer patients can do right now.
For patients taking Tamoxifen as part of breast cancer treatment or prevention, any disruption to the supply chain is more than an inconvenience — it's a threat to a long-term treatment protocol that can span five to ten years. This page provides the latest available information on Tamoxifen supply in 2026 and what patients should know.
Is There a Tamoxifen Shortage in 2026?
As of early 2026, the FDA has not listed Tamoxifen on its national drug shortage database. Multiple generic manufacturers continue to produce tamoxifen 10 mg and 20 mg tablets, and the brand-name liquid formulation Soltamox remains commercially available. At the national level, Tamoxifen supply appears stable.
However, patients continue to report localized difficulties filling their prescriptions. This is a known phenomenon in the generic drug market: a medication can be widely available at the national level while specific pharmacies experience temporary stock-outs due to ordering patterns, supplier changes, or local demand spikes.
What Has the Supply History of Tamoxifen Looked Like?
Tamoxifen has been on the market since the 1970s and became available as a generic medication after patent expiration. It is on the World Health Organization's List of Essential Medicines. While it has never experienced a prolonged national shortage in the United States comparable to drugs like amoxicillin or certain chemotherapy agents, individual manufacturers have faced occasional production disruptions that led to brief regional availability issues.
Because Tamoxifen is an older generic drug, manufacturer margins are thin. This means fewer companies invest in redundant manufacturing capacity — making the supply chain somewhat more fragile than newer, higher-profit drugs, even though absolute availability remains generally good.
Why Are Some Patients Struggling to Find Tamoxifen?
Even without a declared national shortage, the following factors can cause local Tamoxifen availability issues:
- Generic manufacturer consolidation. As the number of manufacturers producing any single generic decreases, supply disruptions at one manufacturer have a larger market impact.
- Pharmacy inventory management. Chain pharmacies use lean inventory models. When demand exceeds forecasts — or when a shipment is delayed — stock runs out quickly.
- Increased prescribing. Breast cancer diagnoses and treatment rates continue to increase, driving higher demand for Tamoxifen year over year.
- Extended therapy duration. As more oncologists follow 10-year Tamoxifen protocols (rather than 5-year), each patient consumes medication for twice as long, further increasing total demand.
What Should Patients Do Right Now?
If you are currently taking Tamoxifen, these steps can protect your supply:
- Refill early. Most insurance plans allow refills when you have 7-10 days of supply remaining. Don't wait until the last day.
- Consider switching to mail-order. Mail-order pharmacies maintain larger inventory and can deliver 90-day supplies directly to your door, eliminating local stock-out risk.
- Expand your pharmacy network. If your usual pharmacy frequently runs out, try filling at an independent pharmacy that sources from a different distributor.
- Contact your oncologist's office if you're running very low. Oncology practices often know which local pharmacies currently have stock and may have samples available in urgent situations.
Should I Stop Tamoxifen If I Can't Find It?
Do not stop Tamoxifen without guidance from your oncologist. Tamoxifen works over years, and adherence to the full prescribed duration is closely tied to long-term outcomes. If you are close to running out, call your oncology team the same day. Most practices have protocols for exactly this situation.
If you need help finding Tamoxifen at a pharmacy near you, medfinder calls pharmacies in your area to check who has your medication in stock, then texts you the results.
If you're considering alternatives while the situation resolves, see our guide: Alternatives to Tamoxifen If You Can't Fill Your Prescription.
Frequently Asked Questions
No. As of early 2026, the FDA has not declared a national shortage of Tamoxifen. However, local pharmacies may temporarily run out due to inventory management and distribution issues, even when the national supply is stable.
Even without a national shortage, local stock-outs can occur due to lean pharmacy inventory systems, supplier delays, increased demand from longer 10-year treatment protocols, and generic manufacturer consolidation. These are typically temporary, localized issues.
Contact your oncologist immediately if you are running low and cannot find Tamoxifen. Do not stop therapy on your own. Your oncology team can often identify nearby pharmacies with stock, provide samples, or advise on temporary alternatives. Interrupting Tamoxifen therapy without medical guidance is not recommended.
The best protection is building a small medication buffer. Refill 7-10 days before you run out, enroll in auto-refill programs, and consider switching to a mail-order pharmacy for 90-day supplies. This eliminates local stock-out risk for most patients.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Tamoxifen also looked for:
More about Tamoxifen
33,257 have already found their meds with Medfinder.
Start your search today.





